BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 10517498)

  • 1. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ; Farese AM; Davis TA; Lind LB; McKearn JP
    Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates.
    Fleming WH; Lankford-Turner P; Turner CW; Wong J; Strobert E; McKearn JP
    Biol Blood Marrow Transplant; 1999; 5(1):8-14. PubMed ID: 10232736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ; Farese AM; Smith WG; Baum CM; Burton E; McKearn JP
    Blood; 2000 Feb; 95(3):837-45. PubMed ID: 10648394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.
    Grigg AP; Roberts AW; Raunow H; Houghton S; Layton JE; Boyd AW; McGrath KM; Maher D
    Blood; 1995 Dec; 86(12):4437-45. PubMed ID: 8541532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.
    Lane TA; Law P; Maruyama M; Young D; Burgess J; Mullen M; Mealiffe M; Terstappen LW; Hardwick A; Moubayed M
    Blood; 1995 Jan; 85(1):275-82. PubMed ID: 7528570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
    Andrews RG; Briddell RA; Knitter GH; Rowley SD; Appelbaum FR; McNiece IK
    Blood; 1995 Jan; 85(1):15-20. PubMed ID: 7528562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells.
    McCubrey JA; Blalock WL; Saleh O; Pearce M; Burrows C; Steelman LS; Lee JT; Franklin RA; Oberhaus SM; Moye PW; Doshi PD; McKearn JP
    Leukemia; 2001 Aug; 15(8):1203-16. PubMed ID: 11480562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
    Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
    Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression.
    Farese AM; MacVittie TJ; Lind LB; Smith WG; McKearn JP
    Stem Cells; 1998; 16 Suppl 2():143-54. PubMed ID: 11012186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
    Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
    Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
    McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
    Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.